Madrigal Pharmaceuticals, Inc.
Release topline data from the blinded arms of MAESTRO-NAFLD-1
Delivered after the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Feb 2021
- Due
- 31 Dec 2021
- Delivered
- January 2022
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“release of topline data from the blinded arms of MAESTRO-NAFLD-1 by the end of the year”
What we found
Evidence strength A What the grades mean
Topline results from the double-blind arms of MAESTRO-NAFLD-1 were announced in January 2022, after the end-2021 deadline.
-
A Madrigal Pharmaceuticals, Inc. 10-Q filed 2022-05-09
“In January, we announced that certain primary and key secondary endpoints from the double-blind, placebo-controlled, 969-patient MAESTRO-NAFLD-1 safety study were achieved” ✓ confirmed on the page
-
A Madrigal Pharmaceuticals, Inc. 10-K filed 2023-02-23
“In January 2022, Madrigal announced topline results from the Phase 3 MAESTRO-NAFLD-1 safety study of resmetirom.” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Commercial launch
- Indicative materiality
- Medium rules
- Action
- Release
- Deliverable
- Topline data from blinded arms of MAESTRO-NAFLD-1
- In the company’s control
- Medium
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Madrigal Pharmaceuticals, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-MDGL-024498 · Corrections policy